uniQure sells off following IPO

It looks as if uniQure's (QURE) underwriters misjudged investor enthusiasm. After pricing its 5.4M-share IPO at $17 (above a range of $13-$15), shares opened at $17 but are now at $16.29, down 4.2%.

The Dutch gene therapy treatment developer currently has a market cap of $287M.


From other sites
Comments (1)
  • eraboin
    , contributor
    Comments (10) | Send Message
    By pricing the share price at $17, UniQure took all the excitement out of their IPO. I hope this isn't an indication of their attitude towards interested stock investors.
    5 Feb 2014, 02:16 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs